Latest Ally Bridge Group (NY) LLC Stock Portfolio

$179Million– No. of Holdings #22

Ally Bridge Group (NY) LLC Performance:

2024 Q1: 12.72%YTD: 12.72%2023: 22.28%

Performance for 2024 Q1 is 12.72%, and YTD is 12.72%, and 2023 is 22.28%.

About Ally Bridge Group (NY) LLC and 13F Hedge Fund Stock Holdings

Ally Bridge Group (NY) LLC is a hedge fund based in NEW YORK, NY. On 31-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $146.7 Millions. In it's latest 13F Holdings report, Ally Bridge Group (NY) LLC reported an equity portfolio of $179.9 Millions as of 31 Mar, 2024.

The top stock holdings of Ally Bridge Group (NY) LLC are BPMC, SLNO, . The fund has invested 8.5% of it's portfolio in BLUEPRINT MEDICINES CORP and 8% of portfolio in SOLENO THERAPEUTICS INC.

The fund managers got completely rid off JASPER THERAPEUTICS INC (JSPR), ARGENX SE - ADR (ARGX) and CYMABAY THERAPEUTICS INC (CBAY) stocks. They significantly reduced their stock positions in OLEMA PHARMACEUTICALS INC (OLMA), GERON CORP (GERN) and MERUS N V (MRUS). Ally Bridge Group (NY) LLC opened new stock positions in BLUEPRINT MEDICINES CORP (BPMC), CG ONCOLOGY INC and VERONA PHARMA PLC (VRNA). The fund showed a lot of confidence in some stocks as they added substantially to PRAXIS PRECISION MEDICINES I (PRAX), AVADEL PHARMACEUTICALS PLC (AVDL) and XENON PHARMACEUTICALS INC (XENE).

Ally Bridge Group (NY) LLC Equity Portfolio Value

Last Reported on: 15 May, 2024

Ally Bridge Group (NY) LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Ally Bridge Group (NY) LLC made a return of 12.72% in the last quarter. In trailing 12 months, it's portfolio return was 50.18%.

New Buys

Ticker	$ Bought
blueprint medicines corp	15,267,700
cg oncology inc	14,064,600
verona pharma plc	11,854,100
mind medicine mindmed inc	9,413,650
jasper therapeutics inc	8,512,730
kura oncology inc	7,786,390
insmed inc	6,782,500
dianthus therapeutics inc	6,509,040

New stocks bought by Ally Bridge Group (NY) LLC

Additions

Ticker	% Inc.
praxis precision medicines i	126
avadel pharmaceuticals plc	57.63
xenon pharmaceuticals inc	27.86
soleno therapeutics inc	8.56

Additions to existing portfolio by Ally Bridge Group (NY) LLC

Reductions

Ticker	% Reduced
olema pharmaceuticals inc	-15.17
geron corp	-7.11
merus n v	-6.91
promis neurosciences inc	-0.66

Ally Bridge Group (NY) LLC reduced stake in above stock

Sold off

Ticker	$ Sold
compass therapeutics inc	-1,302,020
cymabay therapeutics inc	-11,572,300
harpoon therapeutics inc	-4,870,910
ambrx biopharma inc	-5,487,850
jasper therapeutics inc	-28,871,500
alpine immune sciences inc	-6,809,580
amylyx pharmaceuticals inc	-4,059,380
apellis pharmaceuticals inc	-8,979,000

Ally Bridge Group (NY) LLC got rid off the above stocks

Sector Distribution

Ally Bridge Group (NY) LLC has about 82% of it's holdings in Healthcare sector.

Sector	%
Healthcare	82
Others	18

Market Cap. Distribution

Ally Bridge Group (NY) LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
SMALL-CAP	39.6
MID-CAP	31.1
UNALLOCATED	18
MICRO-CAP	6.6
NANO-CAP	4.6

Stocks belong to which Index?

About 34.5% of the stocks held by Ally Bridge Group (NY) LLC either belong to S&P 500 or RUSSELL 2000 index.

Index	%
Others	65.5
RUSSELL 2000	34.5

Top 5 Winners (%)		%
MNMD	mind medicine mindmed inc	91.5 %
PRAX	praxis precision medicines i	78.4 %
PMN	promis neurosciences inc	66.1 %
MRUS	merus n v	63.5 %
JSPR	jasper therapeutics inc	55.0 %

Top 5 Winners ($)		$
MRUS	merus n v	4.8 M
MNMD	mind medicine mindmed inc	4.5 M
PRAX	praxis precision medicines i	4.3 M
GERN	geron corp	3.3 M
JSPR	jasper therapeutics inc	3.0 M

Top 5 Losers (%)		%
RAPT	rapt therapeutics inc	-61.7 %
OLMA	olema pharmaceuticals inc	-18.1 %
MRNS	marinus pharmaceuticals inc	-7.5 %
XENE	xenon pharmaceuticals inc	-6.3 %
INSM	insmed inc	-2.5 %

Top 5 Losers ($)		$
RAPT	rapt therapeutics inc	-6.1 M
OLMA	olema pharmaceuticals inc	-1.7 M
XENE	xenon pharmaceuticals inc	-0.9 M
MRNS	marinus pharmaceuticals inc	-0.3 M
INSM	insmed inc	-0.2 M

Ally Bridge Group (NY) LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Ally Bridge Group (NY) LLC

Ally Bridge Group (NY) LLC has 22 stocks in it's portfolio. About 65.6% of the portfolio is in top 10 stocks. RAPT proved to be the most loss making stock for the portfolio. MRUS was the most profitable stock for Ally Bridge Group (NY) LLC last quarter.

Last Reported on: 15 May, 2024

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
ALPN	alpine immune sciences inc	0.00	0.00	0.00	sold off	-100

AMAM	ambrx biopharma inc	0.00	0.00	0.00	sold off	-100

AMLX	amylyx pharmaceuticals inc	0.00	0.00	0.00	sold off	-100

APLS	apellis pharmaceuticals inc	0.00	0.00	0.00	sold off	-100

ARGX	argenx se - adr	0.00	0.00	0.00	sold off	-100

AVDL	avadel pharmaceuticals plc	5.14	547,036	9,239,440	added	57.63

AXSM	axsome therapeutics inc	0.00	0.00	0.00	sold off	-100

BPMC	blueprint medicines corp	8.49	160,950	15,267,700	new

CBAY	cymabay therapeutics inc	0.00	0.00	0.00	sold off	-100

CMPX	compass therapeutics inc	0.00	0.00	0.00	sold off	-100

CNTX	context therapeutics inc	0.56	725,951	1,001,810	unchanged	0.00

GERN	geron corp	5.06	2,760,500	9,109,640	reduced	-7.11

HARP	harpoon therapeutics inc	0.00	0.00	0.00	sold off	-100

INSM	insmed inc	3.77	250,000	6,782,500	new

ITCI	intra-cellular therapies inc	0.00	0.00	0.00	sold off	-100

JSPR	jasper therapeutics inc	4.73	289,943	8,512,730	new

JSPR	jasper therapeutics inc	0.00	0.00	0.00	sold off	-100

KURA	kura oncology inc	4.33	365,044	7,786,390	new

LBPH	longboard pharmaceuticals in	3.25	270,559	5,844,070	new

LYRA	lyra therapeutics inc	3.47	1,003,740	6,243,270	new